Skip to content
Screener

Maravai LifeSciences Holdings, Inc. MRVI TriLink — Asset Impairments

Other segment segments

Corporate
$0-100%
Cygnus
$0

Similar metrics at other companies

Andersons Inc. logo
ANDEAgribusiness — Asset impairment
$3.7M
Andersons Inc. logo
ANDERenewables — Asset impairment
$850K
Sun Communities logo
SUIMH / RV — Asset Impairment Charges
$14.1M
Suncoke Energy logo
SXCDomestic Coke — Long-lived asset impairment
$90.1M
Ranger Energy Services logo
RNGRReportable Segment — Impairment of assets
$0
Inseego Corp. logo
INSGReportable Segment — Right-of-use asset impairment
$0-100%

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026.

Filed
May 8, 2026, 4:30 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001823239-26-000024
Line itemSeverance and Other Employee Costs (Benefit)Non-Employee Contract CostsAsset ImpairmentsProfessional FeesTotal
TriLink$(446)$1,979$605$2,138
Cygnus(3)(3)
Corporate9734743
Total$(440)$1,979$605$734$2,878

Item 1. Financial Statements

FAQ

What is Maravai LifeSciences Holdings, Inc.'s trilink — asset impairments?
Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — asset impairments of $605K in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s trilink — asset impairments changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s trilink — asset impairments decreased by 77.6% year-over-year, from $2.7M to $605K.
What does trilink — asset impairments mean?
This represents non-cash charges recognized when the carrying value of an asset within the segment exceeds its fair market value. It serves as a critical indicator of potential declines in the long-term economic utility of the segment's capital investments or technology platforms.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s trilink — asset impairments.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude